ExcelMale
Menu
Home
What's new
Latest activity
Forums
New posts
Search forums
What's new
New posts
Latest activity
Videos
Lab Tests
Doctor Finder
Buy Books
About Us
Men’s Health Coaching
Log in
Register
What's new
Search
Search
Search titles only
By:
New posts
Search forums
Menu
Log in
Register
Navigation
Install the app
Install
More options
Contact us
Close Menu
Forums
Testosterone Replacement, Low T, HCG, & Beyond
When Testosterone Is Not Enough
New guy here - Recently got bloodwork results back
JavaScript is disabled. For a better experience, please enable JavaScript in your browser before proceeding.
You are using an out of date browser. It may not display this or other websites correctly.
You should upgrade or use an
alternative browser
.
Reply to thread
Message
<blockquote data-quote="garruk82" data-source="post: 24448" data-attributes="member: 12215"><p>Went ahead and just copied and pasted everything</p><p></p><p>Testosterone,Free and Total</p><p>Testosterone, Serum 550 ng/dL 348 - 1197 01</p><p>Comment:</p><p>Adult male reference interval is based on a population of lean males</p><p>up to 40 years old.</p><p>Free Testosterone(Direct) 12.6 pg/mL 8.7 - 25.1 02</p><p></p><p>CBC With Differential/Platelet</p><p>WBC 4.9 x10E3/uL 3.4 - 10.8 01</p><p>RBC 4.50 x10E6/uL 4.14 - 5.80 01</p><p>Hemoglobin 14.2 g/dL 12.6 - 17.7 01</p><p>Hematocrit 42.0 % 37.5 - 51.0 01</p><p>MCV 93 fL 79 - 97 01</p><p>MCH 31.6 pg 26.6 - 33.0 01</p><p>MCHC 33.8 g/dL 31.5 - 35.7 01</p><p>RDW 13.3 % 12.3 - 15.4 01</p><p>Platelets 201 x10E3/uL 150 - 379 01</p><p>Neutrophils 48 % 01</p><p>Lymphs 42 % 01</p><p>Monocytes 7 % 01</p><p>Eos 2 % 01</p><p>Basos 1 % 01</p><p>Neutrophils (Absolute) 2.4 x10E3/uL 1.4 - 7.0 01</p><p>Lymphs (Absolute) 2.1 x10E3/uL 0.7 - 3.1 01</p><p>Monocytes(Absolute) 0.3 x10E3/uL 0.1 - 0.9 01</p><p>Eos (Absolute) 0.1 x10E3/uL 0.0 - 0.4 01</p><p>Baso (Absolute) 0.0 x10E3/uL 0.0 - 0.2 01</p><p>Immature Granulocytes 0 % 01</p><p>Immature Grans (Abs) 0.0 x10E3/uL 0.0 - 0.1 01</p><p>Comp. Metabolic Panel (14)</p><p>Glucose, Serum 91 mg/dL 65 - 99 01</p><p>BUN 17 mg/dL 6 - 20 01</p><p>Creatinine, Serum 1.18 mg/dL 0.76 - 1.27 01</p><p>eGFR If NonAfricn Am 81 mL/min/1.73 >59</p><p>eGFR If Africn Am 94 mL/min/1.73 >59</p><p>BUN/Creatinine Ratio 14 8 - 19</p><p>Sodium, Serum 139 mmol/L 134 - 144 01</p><p>Potassium, Serum 4.3 mmol/L 3.5 - 5.2 01</p><p></p><p>Chloride, Serum 99 mmol/L 97 - 108 01</p><p>Carbon Dioxide, Total 24 mmol/L 18 - 29 01</p><p>Calcium, Serum 9.0 mg/dL 8.7 - 10.2 01</p><p>Protein, Total, Serum 6.8 g/dL 6.0 - 8.5 01</p><p>Albumin, Serum 4.6 g/dL 3.5 - 5.5 01</p><p>Globulin, Total 2.2 g/dL 1.5 - 4.5</p><p>A/G Ratio 2.1 1.1 - 2.5</p><p>Bilirubin, Total 0.5 mg/dL 0.0 - 1.2 01</p><p>Alkaline Phosphatase, S 52 IU/L 39 - 117 01</p><p>AST (SGOT) 24 IU/L 0 - 40 01</p><p>ALT (SGPT) 22 IU/L 0 - 44 01</p><p>Lipid Panel w/ Chol/HDL Ratio</p><p>Cholesterol, Total 156 mg/dL 100 - 199 01</p><p>Triglycerides 55 mg/dL 0 - 149 01</p><p>HDL Cholesterol 50 mg/dL >39 01</p><p>Comment 01</p><p>According to ATP-III Guidelines, HDL-C >59 mg/dL is considered a</p><p>negative risk factor for CHD.</p><p>VLDL Cholesterol Cal 11 mg/dL 5 - 40</p><p>LDL Cholesterol Calc 95 mg/dL 0 - 99</p><p>T. Chol/HDL Ratio 3.1 ratio units 0.0 - 5.0</p><p>Please Note: 01</p><p>T. Chol/HDL Ratio</p><p>Men Women</p><p>1/2 Avg.Risk 3.4 3.3</p><p>Avg.Risk 5.0 4.4</p><p>2X Avg.Risk 9.6 7.1</p><p>3X Avg.Risk 23.4 11.0</p><p>DHEA-Sulfate 243.1 ug/dL 138.5 - 475.2 01</p><p>TSH 1.250 uIU/mL 0.450 - 4.500 01</p><p>Luteinizing Hormone(LH), S</p><p>LH 3.3 mIU/mL 1.7 - 8.6 01</p><p>Prostate-Specific Ag, Serum</p><p>Prostate Specific Ag, Serum 0.7 ng/mL 0.0 - 4.0 01</p><p>Roche ECLIA methodology.</p><p>According to the American Urological Association, Serum PSA should</p><p>decrease and remain at undetectable levels after radical</p><p>prostatectomy. The AUA defines biochemical recurrence as an initial</p><p>PSA value 0.2 ng/mL or greater followed by a subsequent confirmatory</p><p>PSA value 0.2 ng/mL or greater.</p><p>Values obtained with different assay methods or kits cannot be used</p><p>interchangeably. Results cannot be interpreted as absolute evidence</p><p>of the presence or absence of malignant disease.</p><p>Estradiol, Sensitive 29.4 pg/mL 8.0 - 35.0 02</p><p></p><p>Total Chol:HDL</p><p>Ratio</p><p>T. Chol/HDL Ratio Men Women 1/2 Avg.Risk 3.4 3.3 Avg.Risk 5.0 4.4 2X Avg.Risk 9.6 7.1 3X Avg.Risk 23.4</p><p>11.0</p><p></p><p>Comp. Metabolic Panel (14)</p><p>ANALYTE REF. INTERVAL LOW HIGH RESULT</p><p>Glucose mg/dL 65-99 91</p><p>Creatinine mg/dL 0.76-1.27 1.18</p><p>Sodium mmol/L 134-144 139</p><p>Potassium mmol/L 3.5-5.2 4.3</p><p>Chloride mmol/L 97-108 99</p><p>Carbon Dioxide mmol/L 18-29 24</p><p>Calcium mg/dL 8.7-10.2 9.0</p><p>Protein, Total, Serum g/dL 6.0-8.5 6.8</p><p>Albumin g/dL 3.5-5.5 4.6</p><p>Globulin, Total g/dL 1.5-4.5 2.2</p><p>A/G Ratio 1.1-2.5 2.1</p><p>Bilirubin, Total mg/dL 0.0-1.2 0.5</p><p>Alkaline Phosphatase, S IU/L 39-117 52</p><p>AST IU/L 0-40 24</p><p>ALT IU/L 0-44 22</p><p>BUN: Creatinine Ratio 8-19 14</p><p>Anion Gap mmol/L 8 - 14 16 H</p><p>estimated GFR</p><p>mL/min/1.73mE2</p><p>> 59 81</p><p>Albumin testing performed on the Roche Modular using the ALB PLUS assay.</p><p>Lipid Panel with Chol/HDL Ratio</p><p>ANALYTE REF. INTERVAL LOW HIGH RESULT</p><p>Total Cholesterol mg/dL 100-199 156</p><p>Triglyceride mg/dL 0-149 55</p><p>HDL-C mg/dL >39 50</p><p>VLDL mg/dL 5-40 11</p><p>LDL(calc) mg/dL 0-99 95</p><p>non-HDL cholesterol mg/dL 0 - 129 106</p><p>Total Chol:HDL Ratio ratio units 0.0-5.0 * 3.1</p><p>TSH</p><p>ANALYTE REF. INTERVAL LOW HIGH RESULT</p><p>TSH uIU/mL 0.450-4.500 1.250</p></blockquote><p></p>
[QUOTE="garruk82, post: 24448, member: 12215"] Went ahead and just copied and pasted everything Testosterone,Free and Total Testosterone, Serum 550 ng/dL 348 - 1197 01 Comment: Adult male reference interval is based on a population of lean males up to 40 years old. Free Testosterone(Direct) 12.6 pg/mL 8.7 - 25.1 02 CBC With Differential/Platelet WBC 4.9 x10E3/uL 3.4 - 10.8 01 RBC 4.50 x10E6/uL 4.14 - 5.80 01 Hemoglobin 14.2 g/dL 12.6 - 17.7 01 Hematocrit 42.0 % 37.5 - 51.0 01 MCV 93 fL 79 - 97 01 MCH 31.6 pg 26.6 - 33.0 01 MCHC 33.8 g/dL 31.5 - 35.7 01 RDW 13.3 % 12.3 - 15.4 01 Platelets 201 x10E3/uL 150 - 379 01 Neutrophils 48 % 01 Lymphs 42 % 01 Monocytes 7 % 01 Eos 2 % 01 Basos 1 % 01 Neutrophils (Absolute) 2.4 x10E3/uL 1.4 - 7.0 01 Lymphs (Absolute) 2.1 x10E3/uL 0.7 - 3.1 01 Monocytes(Absolute) 0.3 x10E3/uL 0.1 - 0.9 01 Eos (Absolute) 0.1 x10E3/uL 0.0 - 0.4 01 Baso (Absolute) 0.0 x10E3/uL 0.0 - 0.2 01 Immature Granulocytes 0 % 01 Immature Grans (Abs) 0.0 x10E3/uL 0.0 - 0.1 01 Comp. Metabolic Panel (14) Glucose, Serum 91 mg/dL 65 - 99 01 BUN 17 mg/dL 6 - 20 01 Creatinine, Serum 1.18 mg/dL 0.76 - 1.27 01 eGFR If NonAfricn Am 81 mL/min/1.73 >59 eGFR If Africn Am 94 mL/min/1.73 >59 BUN/Creatinine Ratio 14 8 - 19 Sodium, Serum 139 mmol/L 134 - 144 01 Potassium, Serum 4.3 mmol/L 3.5 - 5.2 01 Chloride, Serum 99 mmol/L 97 - 108 01 Carbon Dioxide, Total 24 mmol/L 18 - 29 01 Calcium, Serum 9.0 mg/dL 8.7 - 10.2 01 Protein, Total, Serum 6.8 g/dL 6.0 - 8.5 01 Albumin, Serum 4.6 g/dL 3.5 - 5.5 01 Globulin, Total 2.2 g/dL 1.5 - 4.5 A/G Ratio 2.1 1.1 - 2.5 Bilirubin, Total 0.5 mg/dL 0.0 - 1.2 01 Alkaline Phosphatase, S 52 IU/L 39 - 117 01 AST (SGOT) 24 IU/L 0 - 40 01 ALT (SGPT) 22 IU/L 0 - 44 01 Lipid Panel w/ Chol/HDL Ratio Cholesterol, Total 156 mg/dL 100 - 199 01 Triglycerides 55 mg/dL 0 - 149 01 HDL Cholesterol 50 mg/dL >39 01 Comment 01 According to ATP-III Guidelines, HDL-C >59 mg/dL is considered a negative risk factor for CHD. VLDL Cholesterol Cal 11 mg/dL 5 - 40 LDL Cholesterol Calc 95 mg/dL 0 - 99 T. Chol/HDL Ratio 3.1 ratio units 0.0 - 5.0 Please Note: 01 T. Chol/HDL Ratio Men Women 1/2 Avg.Risk 3.4 3.3 Avg.Risk 5.0 4.4 2X Avg.Risk 9.6 7.1 3X Avg.Risk 23.4 11.0 DHEA-Sulfate 243.1 ug/dL 138.5 - 475.2 01 TSH 1.250 uIU/mL 0.450 - 4.500 01 Luteinizing Hormone(LH), S LH 3.3 mIU/mL 1.7 - 8.6 01 Prostate-Specific Ag, Serum Prostate Specific Ag, Serum 0.7 ng/mL 0.0 - 4.0 01 Roche ECLIA methodology. According to the American Urological Association, Serum PSA should decrease and remain at undetectable levels after radical prostatectomy. The AUA defines biochemical recurrence as an initial PSA value 0.2 ng/mL or greater followed by a subsequent confirmatory PSA value 0.2 ng/mL or greater. Values obtained with different assay methods or kits cannot be used interchangeably. Results cannot be interpreted as absolute evidence of the presence or absence of malignant disease. Estradiol, Sensitive 29.4 pg/mL 8.0 - 35.0 02 Total Chol:HDL Ratio T. Chol/HDL Ratio Men Women 1/2 Avg.Risk 3.4 3.3 Avg.Risk 5.0 4.4 2X Avg.Risk 9.6 7.1 3X Avg.Risk 23.4 11.0 Comp. Metabolic Panel (14) ANALYTE REF. INTERVAL LOW HIGH RESULT Glucose mg/dL 65-99 91 Creatinine mg/dL 0.76-1.27 1.18 Sodium mmol/L 134-144 139 Potassium mmol/L 3.5-5.2 4.3 Chloride mmol/L 97-108 99 Carbon Dioxide mmol/L 18-29 24 Calcium mg/dL 8.7-10.2 9.0 Protein, Total, Serum g/dL 6.0-8.5 6.8 Albumin g/dL 3.5-5.5 4.6 Globulin, Total g/dL 1.5-4.5 2.2 A/G Ratio 1.1-2.5 2.1 Bilirubin, Total mg/dL 0.0-1.2 0.5 Alkaline Phosphatase, S IU/L 39-117 52 AST IU/L 0-40 24 ALT IU/L 0-44 22 BUN: Creatinine Ratio 8-19 14 Anion Gap mmol/L 8 - 14 16 H estimated GFR mL/min/1.73mE2 > 59 81 Albumin testing performed on the Roche Modular using the ALB PLUS assay. Lipid Panel with Chol/HDL Ratio ANALYTE REF. INTERVAL LOW HIGH RESULT Total Cholesterol mg/dL 100-199 156 Triglyceride mg/dL 0-149 55 HDL-C mg/dL >39 50 VLDL mg/dL 5-40 11 LDL(calc) mg/dL 0-99 95 non-HDL cholesterol mg/dL 0 - 129 106 Total Chol:HDL Ratio ratio units 0.0-5.0 * 3.1 TSH ANALYTE REF. INTERVAL LOW HIGH RESULT TSH uIU/mL 0.450-4.500 1.250 [/QUOTE]
Insert quotes…
Verification
Post reply
Share this page
Facebook
Twitter
Reddit
Pinterest
Tumblr
WhatsApp
Email
Share
Link
Sponsors
Forums
Testosterone Replacement, Low T, HCG, & Beyond
When Testosterone Is Not Enough
New guy here - Recently got bloodwork results back
This site uses cookies to help personalise content, tailor your experience and to keep you logged in if you register.
By continuing to use this site, you are consenting to our use of cookies.
Accept
Learn more…
Top